These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20535211)

  • 1. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
    Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
    Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
    Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
    Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
    Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down's syndrome: paradox of a tumour repressor.
    Threadgill DW
    Nature; 2008 Jan; 451(7174):21-2. PubMed ID: 18172483
    [No Abstract]   [Full Text] [Related]  

  • 5. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J; Lee JC; Baek KH
    Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.
    Dunlevy L; Bennett M; Slender A; Lana-Elola E; Tybulewicz VL; Fisher EM; Mohun T
    Cardiovasc Res; 2010 Nov; 88(2):287-95. PubMed ID: 20558441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
    Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
    Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1).
    Oladipupo SS; Kabir AU; Smith C; Choi K; Ornitz DM
    Sci Rep; 2018 Oct; 8(1):14724. PubMed ID: 30283071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
    Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
    Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in Down's syndrome: lessons from studies of human and mouse models.
    Rueda N; Flórez J; Martínez-Cué C
    Apoptosis; 2013 Feb; 18(2):121-34. PubMed ID: 23224708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.
    Ahmed MM; Dhanasekaran AR; Tong S; Wiseman FK; Fisher EM; Tybulewicz VL; Gardiner KJ
    Hum Mol Genet; 2013 May; 22(9):1709-24. PubMed ID: 23349361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome.
    Gribble SM; Wiseman FK; Clayton S; Prigmore E; Langley E; Yang F; Maguire S; Fu B; Rajan D; Sheppard O; Scott C; Hauser H; Stephens PJ; Stebbings LA; Ng BL; Fitzgerald T; Quail MA; Banerjee R; Rothkamm K; Tybulewicz VL; Fisher EM; Carter NP
    PLoS One; 2013; 8(4):e60482. PubMed ID: 23596509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.
    Germain M; De Arcangelis A; Robinson SD; Baker M; Tavora B; D'Amico G; Silva R; Kostourou V; Reynolds LE; Watson A; Jones JL; Georges-Labouesse E; Hodivala-Dilke K
    J Pathol; 2010 Feb; 220(3):370-81. PubMed ID: 19967723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.
    Arron JR; Winslow MM; Polleri A; Chang CP; Wu H; Gao X; Neilson JR; Chen L; Heit JJ; Kim SK; Yamasaki N; Miyakawa T; Francke U; Graef IA; Crabtree GR
    Nature; 2006 Jun; 441(7093):595-600. PubMed ID: 16554754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization.
    Watson AR; Pitchford SC; Reynolds LE; Direkze N; Brittan M; Alison MR; Rankin S; Wright NA; Hodivala-Dilke KM
    J Pathol; 2010 Mar; 220(4):435-45. PubMed ID: 19967726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.
    Duchon A; Pothion S; Brault V; Sharp AJ; Tybulewicz VL; Fisher EM; Herault Y
    Behav Brain Res; 2011 Mar; 217(2):271-81. PubMed ID: 21047530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.
    Marechal D; Lopes Pereira P; Duchon A; Herault Y
    PLoS One; 2015; 10(2):e0115302. PubMed ID: 25706610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
    Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
    PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
    De Vita S; Canzonetta C; Mulligan C; Delom F; Groet J; Baldo C; Vanes L; Dagna-Bricarelli F; Hoischen A; Veltman J; Fisher EM; Tybulewicz VL; Nizetic D
    Oncogene; 2010 Nov; 29(46):6102-14. PubMed ID: 20697343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.